Extragonadal Embryonal Carcinoma
NCI Definition: An embryonal carcinoma that develops as a primary tumor in an anatomic site other than the testis or ovary. 
There are 6 clinical trials for extragonadal embryonal carcinoma, of which 6 are open and 0 are completed or closed. Of the trials that contain extragonadal embryonal carcinoma as an inclusion criterion, 2 are phase 1 (2 open) and 4 are phase 2 (4 open).
Ipilimumab, nivolumab, and aldesleukin are the most common interventions in extragonadal embryonal carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.